Search Results - S. Vincent Rajkumar

Refine Results
  1. 1

    Multiple myeloma with acute light chain cast nephropathy by Nelson Leung, S. Vincent Rajkumar

    Published in Blood Cancer Journal (2023-03-01)
    Get full text
    Article


  2. 2

    Spontaneous Tumor Lysis Syndrome in the Setting of B-Cell Lymphoma by Mateusz Opyrchal, Travis Figanbaum, Amit Ghosh, Vincent Rajkumar, Sean Caples

    Published in Case Reports in Medicine (2010-01-01)
    Get full text
    Article


  3. 3

    P975: THREE-DIMENSIONAL TELOMERE PROFILING PREDICTS RISK OF RELAPSE IN NEWLY DIAGNOSED MULTIPLE MYELOMA PATIENTS by Shaji Kumar, Vincent Rajkumar, Dragan Jevremovic, Robert Kyle, Sabine Mai, Sherif Louis

    Published in HemaSphere (2023-08-01)
    Get full text
    Article


  4. 4

    Artificial intelligence-enabled screening strategy for drug repurposing in monoclonal gammopathy of undetermined significance by Alexander J. Ryu, Shaji Kumar, Angela Dispenzieri, Robert A. Kyle, S. Vincent Rajkumar, Thomas C. Kingsley

    Published in Blood Cancer Journal (2023-02-01)
    Get full text
    Article


  5. 5

    Anti-myeloma activity of Akt inhibition is linked to the activation status of PI3K/Akt and MEK/ERK pathway. by Vijay Ramakrishnan, Teresa Kimlinger, Jessica Haug, Utkarsh Painuly, Linda Wellik, Timothy Halling, S Vincent Rajkumar, Shaji Kumar

    Published in PLoS ONE (2012-01-01)
    Get full text
    Article


  6. 6

    Once-weekly bortezomib as the standard of care in multiple myeloma: results from an international survey of physicians by Rahul Banerjee, Bo Wang, Larry D. Anderson, Georgia McCaughan, Nikita Mehra, Andrew J. Cowan, S. Vincent Rajkumar, Gurbakhash Kaur

    Published in Blood Cancer Journal (2023-11-01)
    Get full text
    Article


  7. 7

    Extramedullary myeloma is genomically complex and characterized by near-universal MAPK pathway alterations by Saurabh Zanwar, Joseph Novak, Wilson Gonsalves, Michael Howe, Esteban Braggio, S. Vincent Rajkumar, Moritz Binder, Dragan Jevremovic, Surendra Dasari, Shaji Kumar

    Published in Blood Advances (2025-08-01)
    Get full text
    Article


  8. 8

    Histone deacetylase inhibition in combination with MEK or BCL-2 inhibition in multiple myeloma by Vijay G. Ramakrishnan, Kevin C. Miller, Elaine P. Macon, Teresa K. Kimlinger, Jessica Haug, Sanjay Kumar, Wilson I. Gonsalves, S. Vincent Rajkumar, Shaji K. Kumar

    Published in Haematologica (2019-10-01)
    Get full text
    Article


  9. 9

    Performance of newer myeloma staging systems in a contemporary, large patient cohort by Ghulam Rehman Mohyuddin, Samuel M. Rubinstein, Shaji Kumar, S. Vincent Rajkumar, Rafael Fonseca, Nadine H. Abdallah, Gregory S. Calip, Xiaoyan Wang, Christina M. Parrinello, Douglas Sborov

    Published in Blood Cancer Journal (2024-06-01)
    Get full text
    Article


  10. 10

    Once-weekly versus twice-weekly bortezomib in newly diagnosed multiple myeloma: a real-world analysis by Fieke W. Hoff, Rahul Banerjee, Adeel M. Khan, Georgia McCaughan, Bo Wang, Xiaoliang Wang, James Roose, Larry D. Anderson, Andrew J. Cowan, S. Vincent Rajkumar, Gurbakhash Kaur

    Published in Blood Cancer Journal (2024-03-01)
    Get full text
    Article


  11. 11

    Real-world characteristics and outcomes of patients with high-risk and non-high-risk smoldering multiple myeloma using the Flatiron Health database by S. Vincent Rajkumar, María-Victoria Mateos, Marcy Schaeffer, Xiwu Lin, Sacheeta Bathija, Niodita Gupta-Werner, Annette Lam, Robin Carson, Robyn Dennis, Shuchita Kaila, Kathryn Matt, Joana Duran, Sagar Lonial

    Published in Blood Cancer Journal (2024-12-01)
    Get full text
    Article


  12. 12

    Carfilzomib prescribing patterns and outcomes for relapsed or refractory multiple myeloma: a real-world analysis by Sharlene Dong, Rahul Banerjee, Adeel M. Khan, Mengru Wang, Xiaoliang Wang, Anosheh Afghahi, Aimaz Afrough, Murali Janakiram, Bo Wang, Andrew J. Cowan, Adam S. Sperling, Larry D. Anderson, S. Vincent Rajkumar, Gurbakhash Kaur

    Published in Blood Cancer Journal (2025-03-01)
    Get full text
    Article


  13. 13

    A detailed evaluation of the current renal response criteria in AL amyloidosis: is it time for a revision? by Nelson Leung, Siobhan V. Glavey, Shaji Kumar, Angela Dispenzieri, Francis K. Buadi, David Dingli, Martha Q. Lacy, Suzanne R. Hayman, John A. Lust, Stephen J. Russell, Steven R. Zeldenrust, S. Vincent Rajkumar, Morie A. Gertz

    Published in Haematologica (2013-06-01)
    Get full text
    Article


  14. 14

    P812: PREDICTING HIGH-RISK DISEASE BIOLOGY USING ARTIFICIAL INTELLIGENCE BASED FDG PET/CT RADIOMICS IN NEWLY DIAGNOSED MULTIPLE MYELOMA by Jacob Shreve, Charalampos Charalampous, Taxiarchis Kourelis, Josh Pritchett, Yi Hwa, Jonas Paludo, Wilson Gonsalves, Yi Lin, Mithun Shah, Miriam Hobbs, Joselle Cook, Martha Lacy, Angela Dispenzieri, Stephen Broski, Vincent Rajkumar, Shaji Kumar, Moritz Binder

    Published in HemaSphere (2023-08-01)
    Get full text
    Article


  15. 15

    P921: ARTIFICIAL INTELLIGENCE BASED FDG PET/CT RADIOMICS FOR RISK STRATIFICATION IN NEWLY DIAGNOSED MULTIPLE MYELOMA by Jacob Shreve, Charalampos Charalampous, Rahma Warsame, Josh Pritchett, Prashant Kapoor, Francis Buadi, Jonas Paludo, David Dingli, Mithun Shah, Amie Fonder, Suzanne Hayman, Nelson Leung, Morie Gertz, Robert Kyle, Stephen Broski, Vincent Rajkumar, Shaji Kumar, Moritz Binder

    Published in HemaSphere (2023-08-01)
    Get full text
    Article


  16. 16

    A pooled analysis of outcomes according to cytogenetic abnormalities in patients receiving ixazomib- vs placebo-based therapy for multiple myeloma by Wee-Joo Chng, Sagar Lonial, Gareth J. Morgan, Shinsuke Iida, Philippe Moreau, Shaji K. Kumar, Philip Twumasi-Ankrah, Miguel Villarreal, Ajeeta B. Dash, Alexander Vorog, Xiaoquan Zhang, Kaveri Suryanarayan, Richard Labotka, Meletios A. Dimopoulos, S. Vincent Rajkumar

    Published in Blood Cancer Journal (2023-01-01)
    Get full text
    Article


  17. 17

    Progression-free survival as a surrogate endpoint in myeloma clinical trials: an evolving paradigm by Charlotte Pawlyn, Fredrik H. Schjesvold, David A. Cairns, L. J. Wei, Faith Davies, Omar Nadeem, Haifaa Abdulhaq, Maria-Victoria Mateos, Jacob Laubach, Katja Weisel, Heinz Ludwig, S. Vincent Rajkumar, Pieter Sonneveld, Graham Jackson, Gareth Morgan, Paul G. Richardson

    Published in Blood Cancer Journal (2024-08-01)
    Get full text
    Article


  18. 18

    The Effect of Duration of Lenalidomide Maintenance and Outcomes of Different Salvage Regimens in Patients with Multiple Myeloma (MM) by Matthew Ho, Saurabh Zanwar, Prashant Kapoor, Morie Gertz, Martha Lacy, Angela Dispenzieri, Suzanne Hayman, David Dingli, Francis Baudi, Eli Muchtar, Nelson Leung, Taxiarchis Kourelis, Rahma Warsame, Amie Fonder, Lisa Hwa, Miriam Hobbs, Robert Kyle, S. Vincent Rajkumar, Shaji Kumar

    Published in Blood Cancer Journal (2021-09-01)
    Get full text
    Article


  19. 19

    Translocation t(11;14) and survival of patients with light chain (AL) amyloidosis by Alan H. Bryce, Rhett P. Ketterling, Morie A. Gertz, Martha Lacy, Ryan A. Knudson, Steven Zeldenrust, Shaji Kumar, Suzanne Hayman, Francis Buadi, Robert A. Kyle, Philip R. Greipp, John A. Lust, Stephen Russell, S. Vincent Rajkumar, Rafael Fonseca, Angela Dispenzieri

    Published in Haematologica (2009-03-01)
    Get full text
    Article


  20. 20

    Cumulative deficits frailty index and relationship status predict survival in multiple myeloma by Nadine Abdallah, Paul Dizona, Amanika Kumar, Betsy LaPlant, Terri Menser, Gavin Schaeferle, Sarah Aug, Megan Weivoda, Angela Dispenzieri, Francis K. Buadi, Rahma Warsame, Joselle Cook, Martha Q. Lacy, Suzanne Hayman, Morie A. Gertz, S. Vincent Rajkumar, Shaji K. Kumar

    Published in Blood Advances (2025-03-01)
    Get full text
    Article


Search Tools: